To: Rhonda Robb Re: Separation Agreement and Release Dear Rhonda:Cardiovascular Systems Inc • August 18th, 2022 • Surgical & medical instruments & apparatus • Minnesota
Company FiledAugust 18th, 2022 Industry JurisdictionAs you know, your employment with Cardiovascular Systems, Inc. (“CSI”) will end effective at the close of business on June 6, 2022 (the “Separation Date). The purpose of this Separation Agreement and Release letter (“Agreement”) is to set forth the Salary Continuation Benefits and other benefits CSI will provide to you in exchange for your agreement to the terms and conditions of this Agreement. Capitalized terms used but not otherwise defined in this Agreement will have the meaning set forth in CSI’s Executive Officer Severance Plan dated August 22, 2018 (the “Executive Officer Severance Plan”). Please note that while we are giving this Agreement to you now for review, you may not execute this Agreement before your Separation Date.
Ryan Egeland [ADDRESS REDACTED] Re: Separation Agreement and Release Dear Ryan:Cardiovascular Systems Inc • May 5th, 2022 • Surgical & medical instruments & apparatus • Minnesota
Company FiledMay 5th, 2022 Industry JurisdictionAs you know, your employment with Cardiovascular Systems, Inc. (“CSI”) will end effective at the close of business on March 3, 2022 (the “Separation Date). The purpose of this Separation Agreement and Release letter (“Agreement”) is to set forth the Salary Continuation Benefits and other benefits CSI will provide to you pursuant to the terms and conditions of CSI’s Executive Officer Severance Plan dated August 22, 2018 (the “Executive Officer Severance Plan”) in exchange for your agreement to the terms and conditions of this Agreement. Capitalized terms used but not otherwise defined in this Agreement will have the meaning set forth in Executive Officer Severance Plan. Please note that while we are giving this Agreement to you now for review, you may not execute this Agreement before your Separation Date.